-
1Academic Journal
المؤلفون: Rangel, Yully Andrea, Espinosa, Eugenia
المصدر: Biomedica; Vol. 42 No. 3 (2022); 429-434 ; Biomédica; Vol. 42 Núm. 3 (2022); 429-434 ; 2590-7379 ; 0120-4157
مصطلحات موضوعية: Intellectual disability, dystonia, deep brain stimulation, genetic diseases, inborn, dystonic disorders, movement disorders, discapacidad intelectual, distonía, estimulación cerebral profunda, enfermedades genéticas congénitas, trastornos distónicos, trastornos del movimiento
وصف الملف: application/pdf; text/xml
Relation: https://revistabiomedica.org/index.php/biomedica/article/view/6296/5127; https://revistabiomedica.org/index.php/biomedica/article/view/6296/5149; Meyer E, Carss KJ, Rankin J, Nichols JME, Grozeva D, Joseph AP, et al. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia. Nat Genet. 2017;49:223-37. https://doi.org/10.1038/ng.3740; Carecchio M, Invernizzi F, González-Latapi P, Panteghini C, Zorzi G, Romito L, et al. Frequency and phenotypic spectrum of KMT2B dystonia in childhood: A single-center cohort study. Mov Disord. 2019;34:1516-27. https://doi.org/10.1002/mds.27771; Gorman KM, Meyer E, Kurian MA. Review of the phenotype of early-onset generalised progressive dystonia due to mutations in KMT2B. Eur J Paediatr Neurol. 2018;22:245-56. https://doi.org/10.1016/j.ejpn.2017.11.009; Kawarai T, Miyamoto R, Nakagawa E, Koichihara R, Sakamoto T, Mure H, et al. Phenotype variability and allelic heterogeneity in KMT2B -associated disease. Parkinsonism Relat Disord. 2018;52:55-61. https://doi.org/10.1016/j.parkreldis.2018.03.022; Marogianni C, Georgouli D, Dadouli K, Ntellas P, Rikos D, Hadjigeorgiou GM, et al. Identification of a novel de novo KMT2B variant in a Greek dystonia patient via exome sequencing genotype-phenotype correlations of all published cases. Mol Biol Rep. 2021;48:371-9. https://doi.org/10.1007/s11033-020-06057-3; Zech M, Jech R, Havránková P, Fečíková A, Berutti R, Urgošík D, et al. KMT2B rare missense variants in generalized dystonia. Mov Disord. 2017;32:1087-91. https://doi.org/10.1002/mds.27026; Zech M, Boesch S, Jochim A, Weber S, Meindl T, Schormair B, et al. Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up. Mov Disord. 2017;32:549-59. https://doi.org/10.1002/mds.26808; Powis AZ, Towne MC, Hagman KDF, Blanco K, Palmaer E, Castro A, et al. Clinical diagnostic exome sequencing in dystonia: Genetic testing challenges for complex conditions. Clin Genet. 2020;97:305-11. https://doi.org/10.1111/cge.13657; Dafsari HS, Sprute R, Wunderlich G, Daimagüler HS, Karaca E, Contreras A, et al. Novel mutations in KMT2B offer pathophysiological insights into childhood-onset progressive dystonia. J Hum Genet. 2019;64:803-13. https://doi.org/10.1038/s10038-019-0625-1; Mohammad SS, Paget SP, Dale RC. Current therapies and therapeutic decision making for childhood-onset movement disorders. Mov Disord. 2019;34:637-56. https://doi.org/10.1002/mds.27661; Akano E, Otite F, Lavenstein B, Ehrlich D. Indications, outcomes and cost of pediatric deep brain stimulation surgeries in the United States: An analysis of the Kids’ inpatient sample (P4.8-021). Neurology. 2019;92:4.8-021.; https://revistabiomedica.org/index.php/biomedica/article/view/6296
-
2Academic Journal
مصطلحات موضوعية: Distrofia muscular ligada a X, Distrofia muscular de Duchenne, Distrofia muscular de Becker, Duplicación, Distrofinopatías, X-linked muscular dystrophy, Duchenne muscular dystrophy, Becker, Muscular dystrophy, Duplication, Dystrophinopathies
وصف الملف: application/pdf; text/html; application/xml; application/epub+zip; audio/mpeg
Relation: Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiological reviews. 2002;82(2):291-329. doi:10.1152/physrev.00028.2001. 2. Muntoni F, Melis MA, Ganau A, Dubowitz V. Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy. American journal of human genetics. 1995;56(1):151-7. 3. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. The Lancet Neurology. 2003;2(12):731-40. 4. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. The Lancet Neurology. 2010;9(1):77-93. doi:10.1016/S1474-4422(09)70271-6. 5. Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike JD, et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. The New England journal of medicine. 1988;318(21):1363-8. doi:10.1056/NEJM198805263182104 6. Essex C, Roper H. Lesson of the week: late diagnosis of Duchenne's muscular dystrophy presenting as global developmental delay. BMJ. 2001;323(7303):37-8. 7. Bushby KM, Gardner-Medwin D, Nicholson LV, Johnson MA, Haggerty ID, Cleghorn NJ, et al. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. Journal of neurology. 1993;240(2):105-12. 8. Ministerio de Salud y Protección Social, Departamento Administrativo de Ciencia Tecnología e Innovación - Colciencias. Guía de práctica clínica, para la detección temprana, atención integral, seguimiento y rehabilitación de pacientes con diagnóstico de distrofia muscular. Guía No. 37. Bogotá: Ministerio de Salud y Protección Social; 2015. p. 694. 9. Hegde MR, Chin EL, Mulle JG, Okou DT, Warren ST, Zwick ME. Microarray-based mutation detection in the dystrophin gene. Human mutation. 2008;29(9):1091-9. doi:10.1002/humu.20831. 10. Stockley TL, Akber S, Bulgin N, Ray PN. Strategy for comprehensive molecular testing for Duchenne and Becker muscular dystrophies. Genetic testing. 2006;10(4):229-43. doi:10.1089/gte.2006.10.229. 11. Gatta V, Scarciolla O, Gaspari AR, Palka C, De Angelis MV, Di Muzio A, et al. Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA). Human genetics. 2005;117(1):92-8. doi:10.1007/s00439-005-1270-7. 12. Janssen B, Hartmann C, Scholz V, Jauch A, Zschocke J. MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics. 2005;6(1):29-35. doi:10.1007/s10048-004-0204-1. 13. Hamed SA, Hoffman EP. Automated sequence screening of the entire dystrophin cDNA in Duchenne dystrophy: point mutation detection. American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2006;141B(1):44-50. doi:10.1002/ajmg.b.30234. 14. Nicholson LV, Johnson MA, Gardner-Medwin D, Bhattacharya S, Harris JB. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta neuropathologica. 1990;80(3):239-50. 15. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988;2(1):90-5. 16. Aartsma-Rus A, Van Deutekom JC, Fokkema IF, Van Ommen GJ, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle & nerve. 2006;34(2):135-44. doi:10.1002/mus.20586. 17. Vengalil S, Preethish-Kumar V, Polavarapu K, Mahadevappa M, Sekar D, Purushottam M, et al. Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Confirmed by Multiplex Ligation-Dependent Probe Amplification: Genotype-Phenotype Correlation in a Large Cohort. J Clin Neurol. 2017;13(1):91-7. doi:10.3988/jcn.2017.13.1.91. 18. Yang J, Li SY, Li YQ, Cao JQ, Feng SW, Wang YY, et al. MLPA-based genotype-phenotype analysis in 1053 Chinese patients with DMD/BMD. BMC medical genetics. 2013;14:29. doi:10.1186/1471-2350-14-29. 19. Guo R, Zhu G, Zhu H, Ma R, Peng Y, Liang D, et al. DMD mutation spectrum analysis in 613 Chinese patients with dystrophinopathy. Journal of human genetics. 2015;60(8):435-42. doi:10.1038/jhg.2015.43. 20. Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Gappmaier E, Howard MT, et al. Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Human mutation. 2009;30(12):1657-66. doi:10.1002/humu.21114. 21. Juan-Mateu J, Gonzalez-Quereda L, Rodriguez MJ, Baena M, Verdura E, Nascimento A, et al. DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations. PloS one. 2015;10(8):e0135189. doi:10.1371/journal.pone.0135189. 22. Hu XY, Ray PN, Worton RG. Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. The EMBO journal. 1991;10(9):2471-7. 23. White SJ, Aartsma-Rus A, Flanigan KM, Weiss RB, Kneppers AL, Lalic T, et al. Duplications in the DMD gene. Human mutation. 2006;27(9):938-45. doi:10.1002/humu.20367. 24. Tay SK, Ong HT, Low PS. Transaminitis in Duchenne's muscular dystrophy. Annals of the Academy of Medicine, Singapore. 2000;29(6):719-22. 25. Rinaldi C, Wood MJA. Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nature reviews Neurology. 2018;14(1):9-21. doi:10.1038/nrneurol.2017.148. 26. Nelson CE, Robinson-Hamm JN, Gersbach CA. Genome engineering: a new approach to gene therapy for neuromuscular disorders. Nature reviews Neurology. 2017;13(11):647-61. doi:10.1038/nrneurol.2017.126. 27. Lattanzi A, Duguez S, Moiani A, Izmiryan A, Barbon E, Martin S, et al. Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System. Molecular therapy Nucleic acids. 2017;7:11-9. doi:10.1016/j.omtn.2017.02.004. 28. Mah JK. An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy. Methods Mol Biol. 2018;1687:3-17. doi:10.1007/978-1-4939-7374-3_1. 29. McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, et al. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10101):1489-98. doi:10.1016/S0140-6736(17)31611-2. 30. Yilmaz O, Karaduman A, Topaloglu H. Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis. European journal of neurology. 2004;11(8):541-4. doi:10.1111/j.1468-1331.2004.00866.x. 31. Bell JM, Shields MD, Watters J, Hamilton A, Beringer T, Elliott M, et al. Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy. The Cochrane database of systematic reviews. 2017;1:CD010899. doi:10.1002/14651858.CD010899.pub2.; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/920/981; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/920/1014; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/920/1027; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/920/1040; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/920/1054; Núm. 2 , Año 2019 : Mayo - Agosto; 28; Revista Repertorio de Medicina y Cirugía; https://repositorio.fucsalud.edu.co/handle/001/2918; https://doi.org/10.31260/RepertMedCir.v28.n2.2019.920
-
3Academic Journal
مصطلحات موضوعية: Encefalopatía epiléptica STXBP1, epilepsia infantil, síndrome de Ohtahara, trastorno del movimiento, trastorno del comportamiento, trastorno del espectro autista, STXBP1 encephalopathy with epilepsy, epilepsy in childhood, Ohtahara Syndrome, movement disorders, behavior disorders, autism spectrum disorder
وصف الملف: application/pdf; text/html; application/epub+zip; text/xml; audio/mpeg
Relation: Shbarou R, Mikati MA. The Expanding Clinical Spectrum of Genetic Pediatric Epileptic Encephalopathies. Semin Pediatr Neurol. 2016;23(2):134-142. doi:10.1016/j.spen.2016.06.002; Milh M, Riccardi F, Denis J. Genetics of neonatal onset epilepsies: An overview. Rev Neurol (Paris). May 2019. doi:10.1016/j. neurol.2019.01.396; Khaikin Y, Mercimek-Mahmutoglu S. STXBP1 Encephalopathy with Epilepsy. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993. http://www.ncbi.nlm.nih.gov/books/NBK396561/. Accessed June 20, 2019.; Pearl PL. Epilepsy Syndromes in Childhood. Contin Minneap Minn. 2018;24(1, Child Neurology):186-209. doi:10.1212/ CON.0000000000000568; Hussain S, Davanger S. The discovery of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor complexandthemolecularregulationofsynapticvesicletransmitter release: the 2010 Kavli Prize in neuroscience. Neuroscience. 2011;190:12-20. doi:10.1016/j.neuroscience.2011.05.057; Ramakrishnan NA, Drescher MJ, Drescher DG. The SNARE complex in neuronal and sensory cells. Mol Cell Neurosci. 2012;50(1):58-69. doi:10.1016/j.mcn.2012.03.009; Saitsu H, Kato M, Mizuguchi T, et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet. 2008;40(6):782-788. doi:10.1038/ ng.150; Uddin M, Woodbury-Smith M, Chan AJS, et al. Genomic Context Analysis of de Novo STXBP1 Mutations Identifies Evidence of Splice Site DNA-Motif Associated Hotspots. G3amp58 GenesGenomesGenetics. 2018;8(4):1115-1118. doi:10.1534/ g3.118.200080; Swanson DA, Steel JM, Valle D. Identification and Characterization of the Human Ortholog of Rat STXBP1, a Protein Implicated in Vesicle Trafficking and Neurotransmitter Release. Genomics. 1998;48(3):373-376. doi:10.1006/geno.1997.5202; Shen C, Rathore SS, Yu H, et al. The trans-SNARE-regulating function of Munc18-1 is essential to synaptic exocytosis. Nat Commun. 2015;6(1). doi:10.1038/ncomms9852; Toonen RFG, Wierda K, Sons MS, et al. Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size. Proc Natl Acad Sci. 2006;103(48):18332-18337. doi:10.1073/ pnas.0608507103; Suri M, Evers JMG, Laskowski RA, et al. Protein structure and phenotypic analysis of pathogenic and population missense variants in STXBP1. Mol Genet Genomic Med. 2017;5(5):495-507. doi:10.1002/mgg3.304; Verhage M. Synaptic Assembly of the Brain in the Absence of Neurotransmitter Secretion. Science. 2000;287(5454):864-869. doi:10.1126/science.287.5454.864; Yamamoto T, Shimojima K, Yano T, et al. Loss-of-function mutations of STXBP1 in patients with epileptic encephalopathy. Brain Dev. 2016;38(3):280-284. doi:10.1016/j.braindev.2015.09.004; Zhou P, He N, Zhang J-W, et al. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies. Genes Brain Behav. 2018;17(8):e12456. doi:10.1111/gbb.12456; Patzke C, Han Y, Covy J, et al. Analysis of conditional heterozygous STXBP1 mutations in human neurons. J Clin Invest. 2015;125(9):3560-3571. doi:10.1172/JCI78612; Yamashita S, Chiyonobu T, Yoshida M, et al. Mislocalization of syntaxin-1 and impaired neurite growth observed in a human iPSC model for STXBP1 -related epileptic encephalopathy. Epilepsia. 2016;57(4):e81-e86. doi:10.1111/epi.13338; The DDD Study, Homozygosity Mapping Collaborative for Autism, UK10K Consortium, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515(7526):209- 215. doi:10.1038/nature13772; Murillo E. Características de las personas con el síndrome STXBP1 en España: implicaciones para el diagnóstico. An Pediatría. May 2019. doi:10.1016/j.anpedi.2019.04.008; Stamberger H, Nikanorova M, Willemsen MH, et al. STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy. Neurology. 2016;86(10):954-962. doi:10.1212/ WNL.0000000000002457; Ortega-Moreno L, Giráldez BG, Verdú A, et al. Nueva mutación en el gen STXBP1 en un paciente con síndrome de Ohtahara no lesional. Neurología. 2016;31(8):523-527. doi:10.1016/j. nrl.2014.10.017; Milh M, Villeneuve N, Chouchane M, et al. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations: STXBP1 and Early Onset Epilepsy. Epilepsia. 2011;52(10):1828-1834. doi:10.1111/j.1528- 1167.2011.03181.x; Saitsu H, Kato M, Okada I, et al. STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern: Haploinsufficiency of STXBP1 in EIEE. Epilepsia. 2010;51(12):2397-2405. doi:10.1111/j.1528-1167.2010.02728.x; Keogh MJ, Daud D, Pyle A, et al. A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late- onset juvenile-onset parkinsonism. neurogenetics. 2015;16(1):65- 67. doi:10.1007/s10048-014-0431-z; Lanoue V, Chai YJ, Brouillet JZ, et al. STXBP1 encephalopathy: Connecting neurodevelopmental disorders with α-synucleinopathies? Neurology. June 2019:10.1212/ WNL.0000000000007786. doi:10.1212/WNL.0000000000007786; Yamamoto T, Imaizumi T, Yamamoto-Shimojima K, et al. Genomic backgrounds of Japanese patients with undiagnosed neurodevelopmental disorders. Brain Dev. June 2019. doi:10.1016/j.braindev.2019.05.007; Campbell IM, Yatsenko SA, Hixson P, et al. Novel 9q34.11 gene deletions encompassing combinations of four Mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1A. Genet Med. 2012;14(10):868-876. doi:10.1038/gim.2012.65; Yuen RKC, Thiruvahindrapuram B, Merico D, et al. Whole-genome sequencing of quartet families with autism spectrum disorder. Nat Med. 2015;21(2):185-191. doi:10.1038/nm.3792; Rezazadeh A, Uddin M, Snead OC, et al. STXBP1 encephalopathy is associated with awake bruxism. Epilepsy Behav. 2019;92:121- 124. doi:10.1016/j.yebeh.2018.12.018; Liu J, Tong L, Song S, et al. Novel and de novo mutations in pediatric refractory epilepsy. Mol Brain. 2018;11(1). doi:10.1186/ s13041-018-0392-5; Kovačević J, Maroteaux G, Schut D, et al. Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy. Brain. 2018;141(5):1350-1374. doi:10.1093/brain/awy046; Uddin M, Woodbury-Smith M, Chan A, et al. Germline and somatic mutations in STXBP1 with diverse neurodevelopmental phenotypes. Neurol Genet. 2017;3(6):e199. doi:10.1212/ NXG.0000000000000199; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/966/1190; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/966/1548; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/966/1547; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/966/1401; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/966/1549; Núm. 3 , Año 2020 : Septiembre-Diciembre; 197; 192; 29; Revista Repertorio de Medicina y Cirugía; https://repositorio.fucsalud.edu.co/handle/001/2942; https://doi.org/10.31260/RepertMedCir.01217273.966
-
4Academic Journal
مصطلحات موضوعية: Encefalitis Rasmussen, Síndrome Rasmussen, Epilepsia parcial continua, Inmunoduladores, Tratamiento, Rasmussen encephalitis, Rasmussen syndrome, Epilepsia partialis continua, Immunomodulator, Treatment
وصف الملف: application/pdf; text/html; application/xml; application/epub+zip; audio/mpeg
Relation: Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain. 2005;128(Pt 3):454-71. 2. Varadkar S, Bien CG, Kruse CA, Jensen FE, Bauer J, Pardo CA, et al. Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol. 2014;13(2):195-205. 3. Dupont S, Gales A, Sammey S, Vidailhet M, Lambrecq V. Late-onset Rasmussen Encephalitis: A literature appraisal. Autoimmun Rev. 2017;16(8):803-10. 4. Paas Y. The pathophysiological mechanism underlying Rasmussen's encephalitis: a debate. Trends Neurosci. 1998;21(11):468-9. 5. Freeman JM. Rasmussen's syndrome: progressive autoimmune multi-focal encephalopathy. Pediatr Neurol. 2005;32(5):295-9. 6. Mameniskiene R, Wolf P. Epilepsia partialis continua: A review. Seizure. 2017;44:74-80. 7. Granata T, Andermann F. Rasmussen encephalitis. Handb Clin Neurol. 2013;111:511-9. 8. Bien CG, Urbach H, Deckert M, Schramm J, Wiestler OD, Lassmann H, et al. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology. 2002;58(2):250-7. 9. Bahi-Buisson N, Nabbout R, Plouin P, Bulteau C, Delalande O, Hertz Pannier L, et al. [Recent advances in pathogenic concepts and therapeutic strategies in Rasmussen's encephalitis]. Rev Neurol. 2005;161(4):395-405. Avancees actuelles sur les concepts pathogeniques et therapeutiques de l'encephalite de Rasmussen. 10. Dubeau F, Sherwin AL. Pharmacologic principles in the management of chronic focal encephalitis. In: Rasmussen T, editor. Chronic Encephalitis and Epilepsy: Rasmussen's Syndrome Boston: Butterworth-Heinemann; 1991. p. 179-92. 11. Hart YM, Cortez M, Andermann F, Hwang P, Fish DR, Dulac O, et al. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology. 1994;44(6):1030-6. 12. Browner N, Azher SN, Jankovic J. Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis. Mov Disord. 2006;21(9):1500-2. 13. Lozsadi DA, Hart IK, Moore AP. Botulinum toxin A improves involuntary limb movements in Rasmussen syndrome. Neurology. 2004;62(7):1233-4. 14. Thilo B, Stingele R, Knudsen K, Boor R, Bien CG, Deuschl G, et al. A case of Rasmussen encephalitis treated with rituximab. Nat Rev Neurol. 2009;5(8):458-62. 15. Laxer K, Wilfong A, Morris GL, Andermann F. Pilot study of Rituximab to treat chronic focal encephalitis. Epilepsia. 2008;49(Supp. 7):121. 16. Grujic J, Bien CG, Pollo C, Rossetti AO. Vagus nerve stimulator treatment in adult-onset Rasmussen's encephalitis. Epilepsy Behav. 2011;20(1):123-5. 17. San-Juan D, Calcaneo Jde D, Gonzalez-Aragon MF, Bermudez Maldonado L, Avellan AM, Argumosa EV, et al. Transcranial direct current stimulation in adolescent and adult Rasmussen's encephalitis. Epilepsy Behav. 2011;20(1):126-31. 18. Bien CG, Tiemeier H, Sassen R, Kuczaty S, Urbach H, von Lehe M, et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia. 2013;54(3):543-50. 19. Hoffman CE, Ochi A, Snead OC, 3rd, Widjaja E, Hawkins C, Tisdal M, et al. Rasmussen's encephalitis: advances in management and patient outcomes. Childs Nerv Syst. 2016;32(4):629-40. 20. Althausen A, Gleissner U, Hoppe C, Sassen R, Buddewig S, von Lehe M, et al. Long-term outcome of hemispheric surgery at different ages in 61 epilepsy patients. 2013;84(5):529-36.; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/922/982; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/922/1016; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/922/1029; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/922/1042; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/922/1056; Núm. 2 , Año 2019 : Mayo - Agosto; 28; Revista Repertorio de Medicina y Cirugía; https://repositorio.fucsalud.edu.co/handle/001/2920; https://doi.org/10.31260/RepertMedCir.v28.n2.2019.922
-
5Academic Journal
المؤلفون: Dias, Pedro A. D.1 (AUTHOR) pedroaddias@gmail.com, Gómez Espinosa, Eugenia Eréndira1 (AUTHOR), Chavira Ramírez, David Roberto2 (AUTHOR), Rangel Negrín, Ariadna1 (AUTHOR) ari_rangel@hotmail.com
المصدر: American Journal of Primatology. Jan2024, Vol. 86 Issue 1, p1-9. 9p.
مصطلحات موضوعية: *MONKEYS, *NOISE control, *PHYSIOLOGICAL stress, *NOISE
مصطلحات جغرافية: MEXICO
-
6Academic Journal
المؤلفون: Espinosa, Eugenia, Mera, Paola, Toledo, Daniel
المصدر: Revista Med; Vol. 26 No. 1 (2018): january - june; 34-44 ; Revista Med; Vol. 26 Núm. 1 (2018): enero - junio; 34-44 ; 1909-7700 ; 0121-5256
وصف الملف: application/xml; application/pdf
Relation: http://revistas.unimilitar.edu.co/index.php/rmed/article/view/3990/3299; http://revistas.unimilitar.edu.co/index.php/rmed/article/view/3990/3307; http://revistas.unimilitar.edu.co/index.php/rmed/article/view/3990
-
7Academic Journal
المؤلفون: Chaske, Roberto, Espinosa, Eugenia, Galvis, Clara, Gómez, Heidy, Ruiz, Lina María, Toledo, Daniel, Velez Florez, German Eduardo
المصدر: Revista Med; Vol. 26 No. 1 (2018): january - june; 45-54 ; Revista Med; Vol. 26 Núm. 1 (2018): enero - junio; 45-54 ; 1909-7700 ; 0121-5256
وصف الملف: application/xml; application/pdf
Relation: http://revistas.unimilitar.edu.co/index.php/rmed/article/view/2976/3300; http://revistas.unimilitar.edu.co/index.php/rmed/article/view/2976/3308; http://revistas.unimilitar.edu.co/index.php/rmed/article/view/2976
-
8Academic Journal
المؤلفون: Rangel-Negrín, Ariadna, Gómez-Espinosa, Eugenia Eréndira, Chavira-Ramírez, David Roberto, Dias, Pedro A.D.
المصدر: Science of The Total Environment ; volume 882, page 163585 ; ISSN 0048-9697
-
9Academic Journal
المؤلفون: Carvajal-Barrios, Gustavo Adolfo, Ortiz, Jimena, González, Natalia, Arias, José, Guerrero, Pilar, Espinosa, Eugenia, Velandia-Hurtado, Fernando
المصدر: instname:Universidad del Rosario
مصطلحات موضوعية: Tumor cerebral, Niño, Hipertensión endocraneana, Ganglioglioma, Cefalea, Brain tumour, Child, Intracranial hypertension, Headache
وصف الملف: application/pdf
Relation: https://repository.urosario.edu.co/handle/10336/25039; https://doi.org/10.1016/j.rccan.2018.03.002
-
10Report
المؤلفون: Sánchez,Óscar, Cabarcas,Lissete, Espinosa,Eugenia, Guevara,Johana María, Echeverri-Peña,Olga Yaneth
المصدر: Revista mexicana de pediatría v.86 n.5 2019
مصطلحات موضوعية: Acidemia isovalérica, acidemia orgánica, hiperamonemia neonatal, error innato del metabolismo, acidosis metabólica
وصف الملف: text/html
-
11Academic Journal
المصدر: SSRN Electronic Journal ; ISSN 1556-5068
-
12Academic Journal
المؤلفون: Carreño, Fidias, Ortiz, Fernando, Espinosa, Eugenia, Pérez, Claudia
مصطلحات موضوعية: Discapacidad, Parálisis cerebral, Infancia, Cuidador informal, Carga familiar, Cuidadores, Carga profesionales, Evaluación, Tests
جغرافية الموضوع: Colombia
Relation: 578-588; Revista de Salud Pública; 17; http://hdl.handle.net/11181/4797; http://dx.doi.org/10.15446/rsap.v17n4.35593
-
13Academic Journal
المؤلفون: Rangel Negrín, Ariadna, Coyohua Fuentes, Alejandro, de la Torre Herrera, Amalia, Cano Huertes, Beatriz, Reynoso Cruz, Eduardo, Ceccarelli, Enrico, Gómez Espinosa, Eugenia E., Chavira Ramírez, David R., Moreno Espinoza, Diana E., Canales‐Espinosa, Domingo, Maya Lastra, Natalia, Cruz Miros, Pamela, Cañadas Santiago, Samuel, Garau, Sara, Dias, Pedro A. D.
المساهمون: Consejo Nacional de Ciencia y Tecnología
المصدر: American Journal of Physical Anthropology ; volume 174, issue 3, page 396-406 ; ISSN 0002-9483 1096-8644
-
14Academic Journal
المؤلفون: Espinosa, Eugenia, Montaña, Mónica, Mera, Paola, Echeverri, Olga, Guevara, Johana, Barrera, Luis
المصدر: Revista Med; Vol. 22 No. 1 (2014); 62-67 ; Revista Med; Vol. 22 Núm. 1 (2014); 62-67 ; 1909-7700 ; 0121-5256
مصطلحات موضوعية: acidemia metilmalónica, pancitopenia, Cianocobalamina
وصف الملف: application/pdf
Relation: https://revistas.unimilitar.edu.co/index.php/rmed/article/view/1031/764; Oberholzer VG, Levin B, Burgess EA, Young WF. Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabol- ic acidosis. Arch Dis Child. 1967; (225):492–504.; Fernandes J. Saudubray J, Van den Berghe G, Walter J. Inborn Metabolic Diseases: Diagnosis and Treatment . Springer. 2006. 4th ed. p. 247-257.; Chandler R, Venditti C. Genetic and genomic systems to study methylmalonic acidemia. Mol Genet Metab. 2005; 86(1-2): 34-43.; Dündar H, Ozgül R, Güzel-Ozantürk A, Dursun A, Sivri S, Aliefendioğlu D, et al. A. Microarray based mutational analysis of patients with methylmalonic acidemia: Identification of 10 novel mutations. Mol Genet Metab. 2012; 106(4): 419–23.; Thomä N, Leadley P. Homology modeling of human meth- ylmalonyl-CoA mutase: a structural basis for point muta- tions causing methylmalonic aciduria. Protein Sci, 1996; 5(9):1922–27.; Barshop B. Disorders of valine-Isoleucine Metablism. In Blau N., Hoffmann G., Leonard J., Clarke J., Eds. Physician ' s Guide to the Treatment and Follow-Up of Metabolic Diseases. Springer. 2006. pp. 81–91.; Leonard J., Clarke J., Eds. Physician ' s Guide to the Treatment and Follow-Up of Metabolic Diseases. Springer. 2006. pp. 81–91.; Melo D, Kowaltowski A, Wajner M, Castilho R. Mitochondrial ener- gy metabolism in neurodegeneration associated with methylmalo- nic acidemia. J Bioenerg Biomembr. 2011; 43(1): 39–46.; Nyhan W. Metabolic Emergencies. In Hoffmann G, Zschocke J, Nyhan W. Inherited Metabolic Diseases. Springer. 2010. pp. 351–369.; Imen M, Hanene B, Ichraf K, Aida R, Ilhem T, Naziha K, et al. Methylmalonic acidemia and hyperglycemia: an unusual associa- tion. Brain Dev. 2012; 34(2): 113–4.; Ruiz M, Sanchez, F, Dalmau J, Gomez L. Tratamiento nutricio- nal de los errores innatos del metabolismo (Segunda Ed.). Madrid. 2007. pp. 196–199.; Prada C, Al Jasmi F, Kirk E, Hopp M, Jones O, Leslie N, et al Burrow TA. Cardiac disease in methylmalonic acidemia. J Pediatr. 2011; 159(5): 862–4.; Williams Z, Hurley P, Altiparmak U, Feldon S, Arnold G. Late on- set optic neuropathy in methylmalonic and propionic acidemia. Am J Ophthalmol. 2009;147(5): 929–33.; Lee N, Chien Y, Peng S, Huang A, Liu T, et al. Brain damage by mild metabolic derangements in methylmalonic acidemia. Pediatr Neurol. 2008; 39(5), 325–9.; Bennett M, Whitley R, Rinaldo P. Follow-up testing for metabolic diseases identified by expanded newborn screening using tandem mass spectrometry. Washington. The National Academy of Clinical Biochemistry Ed. 2009. pp. 31–37.; Burton B. Inborn errors of metabolism in infancy: a guide to diag- nosis. Pediatrics, 1998; 102(6): 69.; Manoli I, Venditti C. Methylmalonic Acidemia GeneReviews. In Pagon, R.A., Bird, T. D., & Dolan, C. R. Editors.) GeneReview. University of Washington. Seattle. (2005 - Updated 2010).; Mahfoud A, Domínguez C, Pérez A. Diagnóstico y tratamiento de la aciduria metilmalónica: a propósito de un caso. Rev Invest Clin. 2007;48(1): 99–105.; Morel C, Watkins D, Scott P, Rinaldo P, Rosenblatt D. Prena- tal diagnosis for methylmalonic acidemia and inborn errors of vitamin B12 metabolism and transport. Mol Gen Metab. 2005;86(1):160-171.; Pérez V, Hertrampf E, Olivares M. Folato y vitamina B12 en pe- diatría: Mirada actual. Rev Pediatr Electron, 2005; 2(2): 44–52.; Gokcay G, Baykal T, Gokdemir Y, Demirkol M. Breast feeding in organic acidaemias. J Inher Metab Dis. 2006;29(2): 304–10.; Yannicelli S, Acosta P, Velazquez A, Bock H, Marriage B, et al. Improved growth and nutrition status in children with methylmalo- nic or propionic acidemia fed an elemental medical food. Mol Gen Metab. 2003; 80(1): 181–188.; Morris A, Leonard J. Early recognition of metabolic decompensa- tion. Arch Dis Child. 1997; 76(6): 555–6.; Rincón A, Aguado C, Desviat L, Sánchez-Alcudia R, Ugarte M, Pérez B. Propionic and methylmalonic acidemia: antisense thera- peutics for intronic variations causing aberrantly spliced messenger RNA. Am J Hum Genet. 2007;81(6): 1262–70.; Campistol J, Boveda M, Couce M. Protocolo de diagnóstico y tra- tamiento de la acidemia propiónica, metilmalónica e isovalérica. An Esp Pediatr. 1997; 89(1): 9-15.; Kanaumi T, Takashima S, Hirose S, Kodama T, Iwasaki H. Neu- ropathology of methylmalonic acidemia in a child. Pediatr Neurol. 2006;34(2): 156–9.; Ma X, Zhang Y, Yang Y, Liu X, Yang Z, et al. Epilepsy in children with methylmalonic acidemia: electroclinical features and progno- sis. Brain Dev. 2011; 33(9): 790–5.; https://revistas.unimilitar.edu.co/index.php/rmed/article/view/1031
-
15
المؤلفون: Espinosa Eugenia, Martinez Natalia, García Divahia, Lanau Sara
المصدر: Clinical Case Reports and Reviews. 7
مصطلحات موضوعية: Leukoencephalopathy, Pathology, medicine.medical_specialty, business.industry, medicine, General Medicine, General Chemistry, medicine.disease, business
-
16Academic Journal
Alternate Title: Early-onset generalized dystonia caused by a new mutation in the KMT2B gene: Case report.
المؤلفون: Andrea Rangel, Yully1, Espinosa, Eugenia1
المصدر: Revista Biomedica. sep2022, Vol. 42 Issue 3, p429-434. 6p.
-
17Academic Journal
المؤلفون: Colomer Espinosa, Eugenia
المصدر: Cuadernos de teología - Universidad Católica del Norte (On line); Vol. 4 No. 2 (2012): A 50 años del Concilio Vaticano II; 164-181 ; Cuadernos de teología - Universidad Católica del Norte (En línea); Vol. 4 Núm. 2 (2012): A 50 años del Concilio Vaticano II; 164-181 ; 0719-8175
مصطلحات موضوعية: Concilio Vaticano II, Renovación, Perfectae Caritatis, Horizonte, Deificación, II Vatican Council, Renewal, Horizon, Deification
وصف الملف: application/pdf
Relation: https://revistas.ucn.cl/index.php/teologia/article/view/1012/813; https://revistas.ucn.cl/index.php/teologia/article/view/1012
-
18Academic Journal
المؤلفون: Bermúdez, Martha Cecilia, Bernal, Jaime, Espinosa, Eugenia, Cornejo Ochoa, José William, Briceño, Ignacio, Prieto, Juan, Arrieta, Leopoldo, Merinero, Begonia, Pérez, Celia, Ugarte, Magdalena
مصطلحات موضوعية: Homocistinuria, Homocystinuria, Hiperhomocisteinemia, Hyperhomocysteinemia, Cistationina betasintasa, Cystathionine beta-Synthase
وصف الملف: application/pdf
Relation: Act Neurol. Colomb.; http://hdl.handle.net/10495/21557
-
19
المؤلفون: Chaske, Roberto, Espinosa, Eugenia, Galvis, Clara, Gómez, Heidy, Ruiz, Lina María, Toledo, Daniel, Velez Florez, German Eduardo
المصدر: Revista Med; Vol. 26 No. 1 (2018): january-june; 45-54
Revista Med; Vol. 26 Núm. 1 (2018): enero-junio; 45-54وصف الملف: application/xml; application/pdf
-
20
المؤلفون: Carvajal-Barrios, Gustavo Adolfo, Ortiz, Jimena, González, Natalia, Arias, José, Velandia, Fernando, Guerrero, Pilar, Espinosa, Eugenia
المصدر: Revista Colombiana de Cancerología, Volume: 22, Issue: 4, Pages: 180-185, Published: DEC 2018
مصطلحات موضوعية: Tumor cerebral, Hipertensión endocraneana, Niño, Headache, Brain tumour, Cefalea, Child, Intracranial hypertension, Ganglioglioma
وصف الملف: text/html